HomeCompareBYLB vs JNJ

BYLB vs JNJ: Dividend Comparison 2026

BYLB yields 3.65% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BYLB wins by $4.1K in total portfolio value
10 years
BYLB
BYLB
● Live price
3.65%
Share price
$115.00
Annual div
$4.20
5Y div CAGR
15.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.4K
Annual income
$2,542.69
Full BYLB calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — BYLB vs JNJ

📍 BYLB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBYLBJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BYLB + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BYLB pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BYLB
Annual income on $10K today (after 15% tax)
$310.43/yr
After 10yr DRIP, annual income (after tax)
$2,161.29/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, JNJ beats the other by $1,824.70/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BYLB + JNJ for your $10,000?

BYLB: 50%JNJ: 50%
100% JNJ50/50100% BYLB
Portfolio after 10yr
$32.3K
Annual income
$3,616.04/yr
Blended yield
11.18%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BYLB
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BYLB buys
0
JNJ buys
8
PoliticianChamberTickerTypeAmountDate
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002026-01-23
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-12-18
Lloyd Doggett🏢 House$JNJ▲ Buy$1,001 - $15,0002025-12-09
Thomas H. Kean🏢 House$JNJ▼ Sell$15,001 - $50,0002025-11-20
Julie Johnson🏢 House$JNJ▼ Sell$1,001 - $15,0002025-11-13
Rich McCormick🏢 House$JNJ▲ Buy$1,001 - $15,0002025-11-05
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Ro Khanna🏢 House$JNJ▲ Buy$1,001 - $15,0002025-10-30
Jared Moskowitz🏢 House$JNJ▼ Sell$1,001 - $15,0002025-10-10
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBYLBJNJ
Forward yield3.65%2.13%
Annual dividend / share$4.20$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR15.7%28%
Portfolio after 10y$34.4K$30.3K
Annual income after 10y$2,542.69$4,689.40
Total dividends collected$11.9K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BYLB vs JNJ ($10,000, DRIP)

YearBYLB PortfolioBYLB Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,123$422.56$10,592$272.30+$531.00BYLB
2$12,409$508.21$11,289$357.73+$1.1KBYLB
3$13,891$613.10$12,123$472.89+$1.8KBYLB
4$15,606$742.11$13,141$629.86+$2.5KBYLB
5$17,599$901.49$14,408$846.81+$3.2KBYLB
6$19,931$1,099.34$16,021$1,151.60+$3.9KBYLB
7$22,672$1,346.19$18,122$1,588.22+$4.5KBYLB
8$25,915$1,655.86$20,930$2,228.20+$5.0KBYLB
9$29,776$2,046.60$24,792$3,191.91+$5.0KBYLB
10$34,403$2,542.69$30,274$4,689.40+$4.1KBYLB

BYLB vs JNJ: Complete Analysis 2026

BYLBStock

Boyle Bancorp, Inc. operates as the holding company for Farmers National Bank that provides a range of commercial and personal banking services in the United States. It offers checking and savings accounts, money market accounts, certificates of deposits, and IRAs; and auto, recreational vehicle, boat, ATVs/UTVs, CD, marketable security, construction, FHA, VA, home equity, and rural housing loans; fixed rate and adjustable-rate mortgages; business loans, including commercial real estate, multi-family dwellings, commercial construction, business equipment, and lines of credit; agriculture loans comprising farm equipment financing, real estate/farm improvement, operating, refinancing, and sweep loans/accounts; and equine loans consists of mare/stallion and farm financing. The company also provides automated clearing house, remote deposit capture, reorder checks, safe deposit boxes, wire transfer, and overdraft protection services, as well as debit and credit cards; and investment and wealth, brokerage, insurance, ATM, and online and mobile banking services. It operates 12 banking locations in Boyle, Casey, Garrard, Lincoln, and Mercer counties of Kentucky. Boyle Bancorp, Inc. was founded in 1879 and is based in Danville, Kentucky.

Full BYLB Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this BYLB vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BYLB vs SCHDBYLB vs JEPIBYLB vs OBYLB vs KOBYLB vs MAINBYLB vs ABBVBYLB vs MRKBYLB vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.